What Avsola treats
Avsola (infliximab-axxq) is a biosimilar medication designed to treat various chronic inflammatory conditions, including moderate to severe rheumatoid arthritis (RA), Crohn’s disease, ulcerative colitis, plaque psoriasis, and ankylosing spondylitis. By targeting and inhibiting tumor necrosis factor-alpha (TNF-alpha), Avsola helps reduce inflammation and alleviate symptoms, offering significant relief to those suffering from these conditions.
Benefits of Avsola
Patients using Avsola often experience significant improvements, such as reduced joint pain, better control of gastrointestinal symptoms, clearer skin, and improved mobility. The intravenous administration allows for effective delivery of the medication and is typically administered in a healthcare setting, ensuring careful monitoring and dose adjustments.
Possible Side Effects of Avsola
While Avsola is generally well-tolerated, some patients may experience side effects, including upper respiratory infections, headaches, and nausea. Infusion reactions, such as fever, chills, or rash, may also occur. Serious side effects are rare but can include an increased risk of infections, liver enzyme abnormalities, and certain malignancies. It’s important to monitor your health closely and report any unusual symptoms to your healthcare provider.
How infusion works at Prime
Avsola is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Avsola, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Avsola Work?
Avsola works by blocking TNF-alpha, a protein that plays a central role in the inflammatory process. By interfering with TNF-alpha, Avsola effectively reduces inflammation and helps manage symptoms associated with RA, Crohn’s disease, ulcerative colitis, plaque psoriasis, and ankylosing spondylitis. Avsola is administered through intravenous infusion, with dosing tailored to the patient’s specific condition.
Who is Avsola For?
Avsola is suitable for adults and children (6 years and older) with moderate to severe RA, Crohn’s disease, ulcerative colitis, plaque psoriasis, or ankylosing spondylitis, particularly when other treatments have failed or are not suitable. It is often recommended when previous therapies have been ineffective or insufficient.